Daily4 小时
GSK RSV vaccine approved in Canada for adults aged 50-59 at increased risk
Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...
WATTAgNet11 小时
Think strategically in developing IBDV vaccination programs
Developing a vaccination program for infectious bursal disease virus (IBDV) challenges should consider the severity and ...